{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:46:51Z","timestamp":1746337611670},"reference-count":61,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T00:00:00Z","timestamp":1155600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetic Medicine"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> To determine factors predicting isolated postchallenge hyperglycaemia (IPH) defined as fasting plasma glucose (FPG) &lt;\u00a07.0\u00a0mmol\/l and 2\u2010h plasma glucose (2\u2010hPG) \u2265\u00a011.1\u00a0mmol\/l after an oral glucose tolerance test (OGTT) and factors influencing the value of 2\u2010hPG in a population\u2010based study.<\/jats:p><jats:p><jats:bold>Materials and methods\u2003<\/jats:bold> From 15\u00a0005 participants in the Tehran Lipid and Glucose Study (TLGS), we analysed the results of OGTTs in 5386 individuals (2909 women and 2437 men) aged \u2265\u00a020\u00a0years, free of known diabetes and any other disorders influencing glucose metabolism. Logistic and multiple linear regression models were developed to predict IPH and the 2\u2010hPG, respectively.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> The overall prevalence of non\u2010diabetic subjects, IPH and undiagnosed Type 2 diabetes mellitus (FPG \u2265\u00a07.0\u00a0mmol\/l) were 94.5% (<jats:italic>n<\/jats:italic>\u00a0=\u00a05088), 2.5% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0133) and 3.1% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0165), respectively. Of subjects with IPH, 29.3% (<jats:italic>n<\/jats:italic>\u00a0=\u00a039) had FPG levels &lt;\u00a05.6\u00a0mmol\/l. Factors associated with IPH were FPG (mmol\/l) [odds ratio (OR) 11.05, 95% confidence interval (CI) 7.9, 15.4], age \u2265\u00a040\u00a0years (OR 2.0, 95% CI 1.3, 3.2), abnormal waist circumference (OR\u00a02.1, 95% CI 1.4, 3.1) and serum triglycerides \u2265\u00a01.7\u00a0mmol\/l (OR 2.0, 95% CI 1.3, 3.1). In the multiple linear regression model, six explanatory factors (FPG, age, female sex, triglycerides, systolic blood pressure, waist circumference) were positively related to 2\u2010hPG. The model could predict 47.7% of total variance of 2\u2010hPG.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Based on our results in this Iranian population, OGTT can be recommended in subjects with FPG &lt;\u00a07.0\u00a0mmol\/l in the presence of abnormal waist circumference and triglycerides, age \u2265\u00a040\u00a0years and in particular when FPG is close to 7.0\u00a0mmol\/l.<\/jats:p>","DOI":"10.1111\/j.1464-5491.2006.01939.x","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T12:56:45Z","timestamp":1155646605000},"page":"982-989","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS)"],"prefix":"10.1111","volume":"23","author":[{"given":"F.","family":"Hosseinpanah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rambod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Reza Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.12.1859"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04055-0"},{"key":"e_1_2_8_4_2","first-page":"1","article-title":"Comparison of ADA and WHO criteria in detecting glucose disorders in a population based study. Tehran Lipid and Glucose Study","volume":"4","author":"Saadat N","year":"2002","journal-title":"Iranian J Endocrinol Metab"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.11.1886"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.7.1183"},{"key":"e_1_2_8_7_2","volume-title":"Diabetes Mellitus: Report of WHO Study Group.","author":"World Health Organization.","year":"1985"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1990.tb01457.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6940.1323"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.5.785"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.3.430"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.7.1156"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7155.371"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.8.1236"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00059-3"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.3.397"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051249"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812083192302"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-7-199804010-00002"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.8.1397"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051269"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.36.6.689"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050617"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.10.1667"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2007.S11"},{"key":"e_1_2_8_26_2","first-page":"242","article-title":"Tehran Lipid and Glucose Study","volume":"3","author":"Azizi F","year":"2000","journal-title":"CVD Prevention"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2004.03.002"},{"key":"e_1_2_8_28_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low\u2010density lipoprotein cholesterol in plasma, without use of the preoparative ultracentrifuge","volume":"18","author":"Friedewald WT","year":"1972","journal-title":"Clin Chem"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.2.209"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.1.40"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12131-1"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12030-5"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.8.1262"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.920"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1113"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0889-3"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.10.1845"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.10.1851"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.688"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)32479-8"},{"key":"e_1_2_8_41_2","first-page":"489","article-title":"Aging, diabetes, and obesity: standards of normality","volume":"48","author":"Andres R","year":"1981","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.2.S9"},{"key":"e_1_2_8_43_2","first-page":"135A","article-title":"Predictors of change in fasting plasma glucose (FPG) and postchallenge plasma glucose (PCPG) levels in older men and women: the Rancho Bernardo Study 1984\u20131994","volume":"45","author":"Ferrara A","year":"1996","journal-title":"Diabetes"},{"key":"e_1_2_8_44_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/oxfordjournals.aje.a113021","article-title":"Factors associated with the distribution of fasting plasma glucose in an adult community","volume":"112","author":"Barrett\u2010Connor E","year":"1980","journal-title":"Am J Epidemiol"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.2.2.105"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000380200008"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(03)00066-4"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001399"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023606524944"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.5.925"},{"key":"e_1_2_8_51_2","doi-asserted-by":"crossref","unstructured":"ImbeaultP PrinsJB StolicM RussellAW O'Moore\u2010SullivanT DespresJPet al.Aging per se does not influence glucose homeostasis:in vivoandin vitroevidence.Diabetes Care2003;26:480\u2013484.","DOI":"10.2337\/diacare.26.2.480"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(99)90195-6"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.10.1743"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043798-199802000-00003"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051092"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0334"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.2.181"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.2.163"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.2.233"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.2.176"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1211"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00410-3"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-5491.2006.01939.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-5491.2006.01939.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:48:29Z","timestamp":1696956509000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-5491.2006.01939.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1464-5491.2006.01939.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01939.x","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,15]]},"assertion":[{"value":"2006-08-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}